IBT.V - IBEX Technologies Inc.
| Previous Close | 0.8500 |
| Open | 0.9200 |
| Bid | 0.8400 x 0 |
| Ask | 0.9200 x 0 |
| Day's Range | 0.9200 - 0.9200 |
| 52 Week Range | 0.2800 - 1.0000 |
| Volume | |
| Avg. Volume | 24,506 |
| Market Cap | 22.801M |
| Beta (5Y Monthly) | 0.02 |
| PE Ratio (TTM) | 18.40 |
| EPS (TTM) | 0.0500 |
| Earnings Date | Jun 08, 2023 - Jun 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireIBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2023
MONTRÉAL, June 07, 2023 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the third quarter and the nine months ended April 30, 2023. According to Paul Baehr, IBEX President and CEO, “Our net earnings for the quarter increased 57% versus the same period year ago. Revenues were up 2% for this reporting period, well above expectations based on the extremely strong F2022 where customers had built inventories due to COVID
Simply Wall St.Calculating The Intrinsic Value Of IBEX Technologies Inc. (CVE:IBT)
Key Insights IBEX Technologies' estimated fair value is CA$0.74 based on 2 Stage Free Cash Flow to Equity IBEX...
- GlobeNewswire
IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2023
MONTREAL, March 20, 2023 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the second quarter and the six months ended January 31, 2023. “Our results for this reporting period, while lower than year ago, were above expectations since many of our customers were drawing down prior year’s inventories faster than we forecasted. While revenues were down 6% in the period, they were up 31% from the same period in fiscal 2021
- Baystreet
Ag Growth, ATEX, IBEX at 52-Week Highs
Ag Growth International Inc. (T.AFN) hit a new 52-week high of $48.53 Monday. No news stories available ...
- Simply Wall St.
Shareholders Will Probably Hold Off On Increasing IBEX Technologies Inc.'s (CVE:IBT) CEO Compensation For The Time Being
Performance at IBEX Technologies Inc. ( CVE:IBT ) has been reasonably good and CEO Paul Baehr has done a decent job of...
- Simply Wall St.
IBEX Technologies Inc.'s (CVE:IBT) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
IBEX Technologies' (CVE:IBT) stock is up by a considerable 60% over the past month. Given the company's impressive...
- GlobeNewswire
IBEX Reports Results for the First Quarter Ended October 31, 2022
MONTRÉAL, Dec. 15, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the three months ended October 31, 2022. “We are pleased with Q1-F2023 results which were consistent with expectations” said Paul Baehr, IBEX President & CEO. “F2023 revenues are expected to be lower than Fiscal 2022 since the Company received higher than usual purchases from our customers in F2022 as they hedged against COVID-19 related supply
- Simply Wall St.
IBEX Technologies Full Year 2022 Earnings: EPS: CA$0.067 (vs CA$0.031 in FY 2021)
IBEX Technologies ( CVE:IBT ) Full Year 2022 Results Key Financial Results Revenue: CA$7.89m (up 49% from FY 2021). Net...
- GlobeNewswire
IBEX Reports Results for the Year Ended July 31, 2022
MONTRÉAL, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the fiscal year ended July 31, 2022. “IBEX had an impressive year, with EBITDA reaching a record level”, said Mr. Baehr, IBEX President & CEO. “The strong financial performance resulted from record revenues driven by strong sales of heparinase-based products, and by customers increasing their inventories to protect against supply-chain interrupt
- GlobeNewswire
IBEX Technologies Announces Normal Course Issuer Bid
MONTREAL, Aug. 02, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today announced that the TSX Venture Exchange (“TSXV”) has approved IBEX’s normal course issuer bid (“NCIB”). Under the NCIB, IBEX may purchase for cancellation a maximum of 1,800,000 common shares, representing approximately 9.9% of the 18,198,067 shares forming IBEX’s public float. The shares may be purchased through the facilities of the TSXV. The NCIB will commence on August 5, 202
- Simply Wall St.
Are IBEX Technologies Inc.'s (CVE:IBT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
With its stock down 31% over the past three months, it is easy to disregard IBEX Technologies (CVE:IBT). But if you pay...
- GlobeNewswire
IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2022
MONTRÉAL, Québec, June 10, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the nine months ended April 30, 2022. “We are pleased with the continued growth in sales, driven by strong sales of heparinase-based products, as well as by the sales of aryl-acyl amidase, a product used in tests for acetaminophen poisoning; and also with the continued strengthening of the Company’s balance sheet” said Paul Baehr, IBEX P